Lexeo Therapeutics, Inc. Common Stock (LXEO) — Defensive Interval Ratio
Lexeo Therapeutics, Inc. Common Stock (LXEO) has a Defensive Interval Ratio of 2579 days as of December 2025. Defensive assets of $118.77 Million (cash $-, short-term investments $118.77 Million, receivables $-) cover 2579 days of daily cash needs of $46.05K/day. Check Lexeo Therapeutics, Inc. Common Stock (LXEO) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Lexeo Therapeutics, Inc. Common Stock Defensive Interval Ratio (2023–2025)
This chart shows how Lexeo Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 2579 days, meaning defensive assets of $118.77 Million can fund 2579 days of operations without new revenue. Also explore Lexeo Therapeutics, Inc. Common Stock (LXEO) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Lexeo Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for Lexeo Therapeutics, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see LXEO market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2579 days | $118.77 Million | $46.05K/day | $- | $118.77 Million | ▲ +1197 days |
| 2024 | 1382 days | $86.50 Million | $62.59K/day | $- | $86.50 Million | ▲ +1382 days |
| 2023 | 0 days | $0.00 | $47.23K/day | $- | $0.00 | — |